As of March 23, 2026, BridgeBio Pharma's top three insider holders are Global Investors Lp Viking (TenPercentOwner, 18.56Mn shares), Genetic Disorder L.P. Kkr (TenPercentOwner, 13.26Mn shares), Neil Kumar (Chief Executive Officer, 4.48Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Global Investors Lp Viking | 0 | 18,555,375 | 01 Jul, 2025 | |
| Genetic Disorder L.P. Kkr | 0 | 13,260,971 | 14 May, 2025 | |
| Neil Kumar | Chief Executive Officer | 0 | 4,438,447 | 16 Mar, 2026 |
| Charles J Homcy | 916,674 | 0 | 12 Aug, 2025 | |
| Frank Mccormick | 0 | 679,979 | 31 Oct, 2025 | |
| Thomas Trimarchi | President And Cfo | 395,626 | 0 | 20 Mar, 2026 |
| Neil Kumar | Chief Executive Officer | 234,451 | 0 | 23 Feb, 2026 |
| Ali J. Satvat | 165,993 | 0 | 24 Jun, 2025 | |
| Maricel Apuli | Chief Accounting Officer | 136,115 | 0 | 20 Mar, 2026 |
| Brian C Stephenson | Cfo And Treasurer | 102,464 | 0 | 27 Feb, 2025 |
| James C Momtazee | 95,080 | 0 | 24 Jun, 2025 | |
| Frank Mccormick | 83,275 | 0 | 08 Sep, 2025 | |
| Andrew Lo | 14,089 | 50,583 | 19 Nov, 2025 | |
| Richard H Scheller | 53,822 | 0 | 21 Feb, 2023 | |
| Fred Hassan | 25,889 | 0 | 24 Jun, 2025 | |
| Douglas A. Dachille | 0 | 20,000 | 16 Mar, 2022 | |
| Andrea Ellis | 18,589 | 0 | 06 Mar, 2026 | |
| Brent L Saunders | 17,600 | 0 | 03 Jan, 2022 | |
| Ronald J Daniels | 16,991 | 0 | 07 Nov, 2025 | |
| Jennifer E. Cook | 13,741 | 0 | 24 Jun, 2025 | |
| Randal W. Scott | 11,589 | 0 | 18 Feb, 2026 | |
| Hannah Valantine | 7,465 | 0 | 12 Mar, 2026 | |
| Douglas A. Dachille | 6,589 | 0 | 24 Jun, 2025 | |
| Randal W. Scott | 0 | 4,000 | 05 Jun, 2024 | |
| Hannah Valantine | 0 | 398 | 30 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | Maricel Apuli | Common Stock | A | 14,170 | $0.00 | 136,115 | D | A |
| 18 Mar, 2026 | Thomas Trimarchi | Common Stock | A | 59,041 | $0.00 | 395,626 | D | A |
| 17 Mar, 2026 | Neil Kumar | Stock Option (Right to Buy) | A | 40,570 | $0.00 | 40,570 | D | A |
| 17 Mar, 2026 | Neil Kumar | Restricted Stock Units | A | 104,313 | $0.00 | 104,313 | D | A |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 14,337 | $68.48 | 661,349 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 5,363 | $69.32 | 655,986 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 300 | $70.15 | 655,686 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 13,885 | $68.47 | 4,464,562 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 5,815 | $69.29 | 4,458,747 | I | S |
| 12 Mar, 2026 | Neil Kumar | Common Stock | D | 300 | $70.15 | 4,458,447 | I | S |
| 13 Mar, 2026 | Neil Kumar | Common Stock | D | 9,690 | $68.36 | 645,996 | I | S |
| 13 Mar, 2026 | Neil Kumar | Common Stock | D | 10,310 | $69.20 | 635,686 | I | S |
| 13 Mar, 2026 | Neil Kumar | Common Stock | D | 10,241 | $68.39 | 4,448,206 | I | S |
| 13 Mar, 2026 | Neil Kumar | Common Stock | D | 9,759 | $69.23 | 4,438,447 | I | S |
| 10 Mar, 2026 | Hannah Valantine | Common Stock | A | 8,671 | $27.36 | 16,136 | D | M |
| 10 Mar, 2026 | Hannah Valantine | Common Stock | D | 8,671 | $72.00 | 7,465 | D | S |
| 10 Mar, 2026 | Hannah Valantine | Stock Option (Right to Buy) | D | 8,671 | $0.00 | 17,343 | D | M |
| 04 Mar, 2026 | Andrea Ellis | Common Stock | A | 64,921 | $8.45 | 83,510 | D | M |
| 04 Mar, 2026 | Andrea Ellis | Common Stock | D | 64,921 | $64.87 | 18,589 | D | S |
| 04 Mar, 2026 | Andrea Ellis | Stock Option (right to buy) | D | 64,921 | $0.00 | 0 | D | M |